SCHEMBL891544

SCHEMBL891544

[CH2]C(OCCN(C)C)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.68
HRH1 P35367 5/20 0.68
CHRM1 P11229 4/20 0.68
SLC6A2 P23975 4/20 0.68
SLC6A4 P31645 4/20 0.68
SLC6A3 Q01959 4/20 0.68
LMNA P02545 3/20 0.68
CHRM2 P08172 3/20 0.68
ADRA2A P08913 3/20 0.68
OPRM1 P35372 3/20 0.68
DRD3 P35462 3/20 0.68
CYP2D6 P10635 3/20 0.68
CHRM4 P08173 2/20 0.68
CHRM5 P08912 2/20 0.68
ADRA2B P18089 2/20 0.68
CHRM3 P20309 2/20 0.68
HRH2 P25021 2/20 0.68
HTR2C P28335 2/20 0.68
ADRA1A P35348 2/20 0.68
HTR2B P41595 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2424440 0.82 LMNA (0.54) HTR2AHRH1CHRM1SLC6A2SLC6A4
SCHEMBL7524814 0.81 HTR2A (0.72) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL12543374 0.81 SLC6A2 (1.00) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL4064 0.81 SLC6A2 (1.00) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL25219551 0.79 SLC6A2 (0.96) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL10487818 0.79 LMNA (1.00) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL9565209 0.79 SLC6A2 (0.96) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL29205078 0.79 SLC6A2 (0.96) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL28210970 0.79 SLC6A2 (0.96) HTR2AHRH1CHRM1SLC6A2SLC6A4
Diphenhydramine SCHEMBL17071 0.79 LMNA (1.00) HTR2AHRH1CHRM1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2510925-B1 Small-Molecule modulators of TRP-P8 activity DENDREON CORP (US) 2016-07-20 EP claimed
EP-2510925-A2 Small-Molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2012-10-17 EP claimed
US-20120083493-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-04-05 US claimed
EP-2268273-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2011-01-05 EP claimed
WO-2009067410-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2009-05-28 WO claimed
EP-1986622-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-11-05 EP claimed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US claimed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US claimed
WO-2007095340-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2007-08-23 WO claimed
EP-2510925-B1 Small-Molecule modulators of TRP-P8 activity DENDREON CORP (US) 2016-07-20 EP disclosed
US-8618155-B2 Small-molecule modulators of Trp-p8 activity DENDREON CORPORATION (US) 2013-12-31 US disclosed
US-8614243-B2 Small-molecule modulators of Trp-p8 activity DENDREON CORPORATION (US) 2013-12-24 US disclosed
EP-2510925-A2 Small-Molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2012-10-17 EP disclosed
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-09-06 US disclosed
US-7741355-B2 Small-molecule modulators of TRP-p8 activity DENDREON CORPORATION (US) 2010-06-22 US disclosed
WO-2009067410-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2009-05-28 WO disclosed
EP-1986622-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-11-05 EP disclosed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US disclosed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US disclosed
WO-2007095340-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity TRPC4, TRPC3, TRPC1 HTR2A 181/4885HRH1 907/4885CHRM1 739/4885
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 HTR2A 181/4885HRH1 907/4885CHRM1 739/4885
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 HTR2A 181/4885HRH1 907/4885CHRM1 739/4885
US-20120083493-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 HTR2A 181/4885HRH1 907/4885CHRM1 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.